Article (Scientific journals)
Group 3 ITI Consensus Report: Materials and antiresorptive drug-associated outcomes in implant dentistry.
Al-Nawas, Bilal; Lambert, France; Andersen, Sanne Werner Møller et al.
2023In Clinical Oral Implants Research, 34 Suppl 26 (S26), p. 169 - 176
Peer Reviewed verified by ORBi
 

Files


Full Text
Group 3 ITI Consensus Report- Materials and antiresorptive drug-associated outcomes in implant dentistry.pdf
Publisher postprint (629.99 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
anti-resorptive drugs; biomaterials; drug delivery; peri-implant tissue integration; pharmacology; structural biology; tissue implant interactions; tissue physiology; wound healing; zirconium oxide; Bone Density Conservation Agents; Titanium; Dental Implants; Alloys; Humans; Bone Density Conservation Agents/adverse effects; Oral Surgery
Abstract :
[en] [en] OBJECTIVES: The aim of Working Group 3 was to address the influence of both material- and anti-resorptive drug- related factors on clinical and biological outcomes and complications in implant dentistry. Focused questions were addressed on (a) implant materials other than titanium (alloy)s, (b) transmucosal abutment materials and (c) medications affecting bone metabolism were addressed. MATERIALS AND METHODS: Three systematic reviews formed the basis for discussion in Group 3. Consensus statements and clinical recommendations were formulated by group consensus based on the findings of the systematic reviews. Patient perspectives and recommendations for future research were also conveyed. These were then presented and accepted following further discussion and modifications as required by the plenary. RESULTS: Zirconia is a valid alternative to titanium as material for implant and transmucosal components, allowing soft and hard tissue integration with clinical outcomes-identified by implant survival, marginal bone loss and peri-implant probing depths-up to 5-years comparable to titatnium. However, most of the evidence for zirconia implants is based on 1-piece implants limiting the indication range. Furthermore, based on expert opinion, zirconia transmucosal components might be preferred in the esthetic zone. In patients receiving low-dose bisphosphonate therapy, the rate of early implant failure is not increased, while the long-term effects remain poorly studied. Although it has not been sufficiently addressed, similar outcomes can be expected with low-dose denosumab. A drug holiday is not recommended when considering implant placement in patients treated with low-dose ARD. However, the specific therapeutic window, the cumulative dose and the administration time should be considered. Access to peri-implant supportive care is mandatory to prevent peri-implantitis-related medication-related osteonecrosis of the jaw (MRONJ) or implant-related sequestra (IRS). In patients receiving low-dose anti-resorptive drugs (ARD) therapy, the risk of complications related to implant placement is high, and implant procedures in this specific population should be strictly treated in a comprehensive multidisciplinary center. Finally, healthy dental implants should not be removed before low or high-dose ARD. CONCLUSIONS: Zirconia implants can be an alternative to titanium implants in selected indications. However, the current state of evidence remains limited, especially for 2-piece implant designs. Administration of low-dose ARD did not show any negative impact on early implant outcomes, but careful follow-up and supportive care is recommended in order to prevent peri-implant MRONJ and IRS. Implant placement in high-dose patients must be strictly considered in a comprehensive multidisciplinary center.
Research Center/Unit :
d‐BRU - Dental Biomaterials Research Unit - ULiège
Disciplines :
Dentistry & oral medicine
Author, co-author :
Al-Nawas, Bilal ;  Department for Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Center of the J. Gutenberg University Mainz, Mainz, Germany
Lambert, France  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de parodontologie, chirurgie bucco-dentaire et chirurgie implantaire
Andersen, Sanne Werner Møller;  Department of Oral and Maxillofacial Surgery, Copenhagen University Hospital, Copenhagen, Denmark
Bornstein, Michael M ;  Department of Oral Health & Medicine, University Center for Dental Medicine Basel UZB, University of Basel, Basel, Switzerland
Gahlert, Michael;  Private Dental Clinic PD Dr. Gahlert & PD Dr. Roehling, Munich, Germany ; Clinic for Oral and Cranio-Maxillofacial Surgery, Hightech Research Center, University Hospital Basel, University of Basel, Basel, Switzerland ; Sigmund Freud Private University, Vienna, Austria
Jokstad, Asbjorn ;  Faculty of Health Sciences, UiT, The Arctic University of Norway, Tromsø, Norway
Jung, Junho;  Department of Oral and Maxillofacial Surgery, College of Dentistry, Kyung Hee University, Seoul, South Korea
Kwon, Yong-Dae ;  Department of Oral and Maxillofacial Surgery, College of Dentistry, Kyung Hee University, Seoul, South Korea
Laleman, Isabelle  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de parodontologie, chirurgie bucco-dentaire et chirurgie implantaire
Oteri, Giacomo;  Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy
Roehling, Stefan;  Private Dental Clinic PD Dr. Gahlert & PD Dr. Roehling, Munich, Germany ; Clinic for Oral and Cranio-Maxillofacial Surgery, Hightech Research Center, University Hospital Basel, University of Basel, Basel, Switzerland ; Clinic for Oral and Cranio-Maxillofacial Surgery, Kantonsspital Aarau, Aarau, Switzerland
Schiegnitz, Eik ;  Head Division of Implantology, Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre of the Johannes Gutenberg-University Mainz, Mainz, Germany
Takeda, Yukihiro;  Private Dental Clinic, Takeda Dental Clinic, Tokyo, Japan ; Department of Oral and Maxillofacial Implantology, Tokyo Dental College, Tokyo, Japan
Terheyden, Hendrik ;  Department of Oral & Maxillofacial Surgery, Helios Kliniken Kassel, Germany
More authors (4 more) Less
Language :
English
Title :
Group 3 ITI Consensus Report: Materials and antiresorptive drug-associated outcomes in implant dentistry.
Publication date :
September 2023
Journal title :
Clinical Oral Implants Research
ISSN :
0905-7161
eISSN :
1600-0501
Publisher :
John Wiley and Sons Inc, Denmark
Volume :
34 Suppl 26
Issue :
S26
Pages :
169 - 176
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 05 February 2024

Statistics


Number of views
153 (3 by ULiège)
Number of downloads
132 (1 by ULiège)

Scopus citations®
 
11
Scopus citations®
without self-citations
9
OpenAlex citations
 
11

publications
0
supporting
0
mentioning
0
contrasting
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Bibliography


Similar publications



Contact ORBi